Answers are grounded in this paper and cite their sources.
Treatment with a long-acting GLP-1 RA increased bone formation by 16% and prevented bone loss after weight loss obtained through a low-calorie diet, supporting its role as a safe weight-lowering agent.
No takes yet. Share an insight, caveat, or question.
Iepsen et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: